...
首页> 外文期刊>Electrophoresis: The Official Journal of the International Electrophoresis Society >Identification of true differentially expressed mRNAs in a pair of human bladder transitional cell carcinomas using an improved differential display procedure
【24h】

Identification of true differentially expressed mRNAs in a pair of human bladder transitional cell carcinomas using an improved differential display procedure

机译:使用改进的差异显示程序鉴定一对人膀胱移行细胞癌中真正差异表达的mRNA

获取原文
获取原文并翻译 | 示例
           

摘要

Differential display in combination with arbitrarily primed polymerase chain reaction (PCR) fingerprinting has become one of the most powerful techniques to identify and isolate mRNAS that are differentially expressed in pairs of biological samples. However, in many cases the cDNA band corresponding to the differentially amplified product contains several cDNA species that comigrate with the cDNA of interest due to the poor resolution of the fingerprinting gels, thus hampering further analysis and identification of the desirable cDNA. To improve the electrophoretic resolution of differentially amplified cDNAs, we have utilized Resolver Gold agarose gel electrophoresis (Ingenius) as an additional step to overcome downstream problems encountered during RNA fingerprinting experiments. To illustrate the power of the modified differential display procedure we present a detailed analysis of the cDNA products differentially displayed in tumor biopsies obtained from a noninvasive (grade ll, Ta) and an invasive (grade lll, T2-T4) human bladder transitional cell carcinoma (TCC). Several genes that were differentially expressed in this tumor pair were identified. These included: tropomyosin 4, the protein disulfide isomerase precursor (PDI), MRP14, signal transducer CD24, keratins 8 and 13, cytochrome oxidase subunit IV (COXIV), putative transcription factor HOX-1.3, as well as two novel genes of yet unknown function. All of the identified cDNAs were shown to be truly differentially expressed by Northern blotting, reverse transcriptase-PCR (RT-PCR), and two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) analysis of the corresponding lesions.
机译:差异显示与任意引发的聚合酶链反应(PCR)指纹结合已成为鉴定和分离在生物样品对中差异表达的mRNA的最强大技术之一。然而,在许多情况下,对应于差异扩增产物的cDNA条带包含几种cDNA种类,它们由于指纹凝胶的较差的分辨率而与目的cDNA竞争,因此妨碍了对所需cDNA的进一步分析和鉴定。为了提高差异扩增cDNA的电泳分辨率,我们利用了Resolver琼脂糖凝胶电泳(Ingenius)作为克服RNA指纹实验中遇到的下游问题的附加步骤。为了说明修改后的差异显示程序的功能,我们对从非侵袭性(II,Ta级)和侵袭性(III,T2-T4级)人膀胱移行细胞癌获得的肿瘤活检中差异显示的cDNA产物进行了详细分析。 (TCC)。鉴定了在该肿瘤对中差异表达的几个基因。其中包括:原肌球蛋白4,蛋白二硫键异构酶前体(PDI),MRP14,信号转导CD24,角蛋白8和13,细胞色素氧化酶亚基IV(COXIV),推定的转录因子HOX-1.3,以及两个未知的新基因功能。通过Northern印迹,逆转录酶-PCR(RT-PCR)和相应病变的二维聚丙烯酰胺凝胶电泳(2-D PAGE)分析显示,所有鉴定出的cDNA均能真正差异表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号